Delivery Order SPE2DR25D3003-SPE2DR26F5QN4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,955.33 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This competitive award, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a firm fixed-price transaction with no set-aside designation. The drug will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $8,232.28 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 13, 2025. This competitive, firm fixed-price delivery order represents a continuation of pharmaceutical supply under AmerisourceBergen's existing contract vehicle with DLA. The award carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $36,094.14 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 MG/ML SureClick auto-injectors. This competitively awarded, firm fixed-price contract was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. The contract carries no set-aside designation, indicating open competition among qualified vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $1,482.80 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pharmaceutical product. The award, issued on July 11, 2025, with an ultimate completion date of July 14, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract...
- The Defense Logistics Agency awarded a delivery order valued at $8,826.84 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical product will...
- The Defense Logistics Agency awarded a delivery order valued at $55,027.37 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 21, 2025. This firm fixed-price contract, awarded on August 20, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $18,426.38 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for REPATHA 140 MG/ML SureClick auto-injector pharmaceutical products, with final delivery due by December 8, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The contract involves...
- The Defense Logistics Agency awarded a delivery order valued at $35,687.57 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, a pharmaceutical product used in cardiovascular disease management. The contract, awarded on October 27, 2025, with an ultimate completion date of October 28, 2025, operates under a firm fixed-price structure with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,735.27 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. The award, issued on December 30, 2025, with a completion date of December 31, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. This delivery order is unset-aside and competitively sourced, consistent with AmerisourceBergen's standard federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $1,041.42. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D3003Indefinite Delivery Contract
- SPE2DR25D3003-SPE2DR26F5QN4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $26,872.01 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside contract was executed on December 30, 2025, with a completion date of December 31, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under a larger indefinite delivery vehicle, leveraging the company's established pharmaceutical supply infrastructure for federal medical procurement. This award falls under AmerisourceBergen Drug Corp's broader relationship with the Defense Logistics Agency's Troop Support Medical division, which includes a significant $999,999,999.00 indefinite delivery contract (SPE2DX) extending through December 2026. The company serves as a primary pharmaceutical vendor supplying the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with an extensive range of medications and medical supplies. REPATHA, a cholesterol-management biologic therapy, supports the military healthcare system's pharmaceutical requirements and reflects AmerisourceBergen's role as a critical distributor of specialized medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.9k | 12/29/25 |